Using PD-L1 for immunotherapy?
21 September 2016 | By Abcam
PD-L1 [28-8] (ab205921) is an ideal tool to quantify PD-L1 expression in patients for PD-1 based therapies....
List view / Grid view
News
First female CEO to lead GSK as Emma Walmsley succeeds Andrew Witty
20 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Emma Walmsley will succeed Andrew Witty as GSK CEO when he retires on 31st March 2017, making her the first female CEO of a major pharmaceuticals company...
GlobalData says Osteoarthritis market to reach $10.5 billion by 2024
20 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The rapid growth of the Osteoarthritis can be attributed to the launch of new therapies priced at a substantial premium to small-molecule therapies...
Faron’s proposed placing and subscription to raise £8 million
20 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The net proceeds of the proposed placing and subscription shares would be used to fund safety trials for the US development...
Inhibiting protein kinase CK2 prevents T cell development, could lead to innovative MS treatment
16 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Inhibition of the protein kinase CK2 results in a blockade of exactly those signal pathways required by TH17 cells in order to evolve...
‘Library’ of de-prioritised pharma compounds available for researchers
UK scientists can apply for MRC funding to use any of the compounds in medical research studies to investigate the underlying mechanics of disease...
Immunological memory of the mucosa: a breakthrough in vaccine research
16 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The mucosa forms a unique immunological antibody memory that does not occur if the vaccine is given by injection, says a study from Sahlgrenska Academy...
Belgian scientists discover missing link in septic shock
15 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers at VIB and Ghent University have discovered an important mechanism of sepsis, an overreaction of the body’s immune system to an infection...
Intercontinental consortium granted €5.1 million to develop breast cancer imaging devices
15 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Grants of more than €5 million, predominantly from the EU, will be used to develop a new imaging device for the diagnosis of breast cancer...
Attendee list released for the Orphan Drugs & Rare Diseases 2016
13 September 2016 | By SMi
SMi Reports (13.09. 2016, London, UK): Alexion, BioMarin, Chiesi, MHRA, NICE to meet in London in October to discuss updates in the orphan drug landscape...
Chemotherapy alternative: research shows Chinese medicine kills cancer cells
8 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Compound kushen injection (CKI) has been used for years in Chinese clinics as an adjunct to western chemotherapy. Researchers used next generation...
Promising preclinical findings for Probiodrug’s glutaminyl cyclase inhibitor
8 September 2016 | By Caroline Richards, Editor, European Pharmaceutical Review & Drug Target Review
In a mouse model of inflammation (thioglycollate-induced peritonitis), PQ912 had an effect on recruitment of macrophages and eosinophils, and levels of chemokines and lipid mediators, which the company believes makes QC inhibition attractive for further evaluation as potential anti-inflammatory drug and/or resolution promoting agent...
JDRF gives $2.5 million for T1D diabetes research agreement with Sernova
8 September 2016 | By Niamh Louise Marriott, Digital Content Producer
A new research funding agreement aims to address people with severe type 1 diabetes (T1D) who are hypoglycemia unaware, a condition in which a person with...
Pancreatic tumour tissue development stopped by vitamin A process
8 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Through a process involving vitamin A, researchers from Imperial College London observed that it was possible to switch off pancreatic stellate cells...
HSRx antiviral drug tests effective against Zika virus
7 September 2016 | By Niamh Louise Marriott, Digital Content Producer
HSRx expects to begin human trials early in 2017 and will seek accelerated drug approval from the U.S. Food & Drug Administration...
